Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Nagle

Showing results (171-180 of 176) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 176 results.
Human Molecular Genetics|October 13, 2000
Mucolipidosis type IV is caused by mutations in a gene encoding a novel transient receptor potential channelM Sun, E Goldin, S Stahl, et al.
Cytotherapy|November 3, 2018
Early positron emission tomography/computed tomography as a predictor of response after CTL019 chimeric antigen receptor -T-cell therapy in B-cell non-Hodgkin lymphomasNirav N Shah, Sarah J Nagle, Drew A Torigian, et al.
Neurology|October 1, 1996
Intraoperative monitoring of motor evoked potentials: a review of 116 casesK J Nagle, R G Emerson, D C Adams, et al.
Journal of the American College of Cardiology|June 15, 2004
Enhancing quality of care for acute myocardial infarction: shifting the focus of improvement from key indicators to process of care and tool use: the American College of Cardiology Acute Myocardial Infarction Guidelines Applied in Practice Project in Michigan: Flint and Saginaw ExpansionRajendra H Mehta, Cecelia K Montoye, Jessica Faul, et al.
Haematologica|May 17, 2020
Brentuximab vedotin in combination with rituximab, cyclophosphamide, doxorubicin, and prednisone as frontline treatment for patients with CD30-positive B-cell lymphomasJakub Svoboda, Steven M Bair, Daniel J Landsburg, et al.
Science (New York, N.Y.)|July 11, 1997
Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasisE D Carstea, J A Morris, K G Coleman, et al.
Pageof 18

Showing results (171-180 of 176) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 176 results.
Human Molecular Genetics|October 13, 2000
Mucolipidosis type IV is caused by mutations in a gene encoding a novel transient receptor potential channelM Sun, E Goldin, S Stahl, et al.
Cytotherapy|November 3, 2018
Early positron emission tomography/computed tomography as a predictor of response after CTL019 chimeric antigen receptor -T-cell therapy in B-cell non-Hodgkin lymphomasNirav N Shah, Sarah J Nagle, Drew A Torigian, et al.
Neurology|October 1, 1996
Intraoperative monitoring of motor evoked potentials: a review of 116 casesK J Nagle, R G Emerson, D C Adams, et al.
Journal of the American College of Cardiology|June 15, 2004
Enhancing quality of care for acute myocardial infarction: shifting the focus of improvement from key indicators to process of care and tool use: the American College of Cardiology Acute Myocardial Infarction Guidelines Applied in Practice Project in Michigan: Flint and Saginaw ExpansionRajendra H Mehta, Cecelia K Montoye, Jessica Faul, et al.
Haematologica|May 17, 2020
Brentuximab vedotin in combination with rituximab, cyclophosphamide, doxorubicin, and prednisone as frontline treatment for patients with CD30-positive B-cell lymphomasJakub Svoboda, Steven M Bair, Daniel J Landsburg, et al.
Science (New York, N.Y.)|July 11, 1997
Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasisE D Carstea, J A Morris, K G Coleman, et al.
Pageof 18